SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-060477
Filing Date
2019-11-06
Accepted
2019-11-06 15:30:37
Documents
16
Period of Report
2019-11-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922012-1_8k.htm   iXBRL 8-K 38496
2 EXHIBIT 99.1 tm1922012d1_ex99-1.htm EX-99.1 19428
3 EXHIBIT 99.2 tm1922012d1_ex99-2.htm EX-99.2 12220
4 GRAPHIC tm1922012d1_ex99-2img001.jpg GRAPHIC 5522
  Complete submission text file 0001104659-19-060477.txt   338154

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA abbv-20191106.xsd EX-101.SCH 4481
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20191106_def.xml EX-101.DEF 30228
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20191106_lab.xml EX-101.LAB 41879
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20191106_pre.xml EX-101.PRE 28431
17 EXTRACTED XBRL INSTANCE DOCUMENT tm1922012-1_8k_htm.xml XML 9315
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 191196127
SIC: 2834 Pharmaceutical Preparations